In another study that investigated the role of intratumor microbiota in CD47-based cancer immunotherapy, Shi et al. (2020) found that colonic Bifidobacterium accumulates in tumor sites and facilitates local anti-CD47 treatment via the STING pathway. This evidence concerns the gene CD47 and cancer.